Astrid Lindgren Children´s Hospital
Stockholm, Region Stockholm, 17176, Sweden
NCT Number: NCT06284616
To implement and evaluate a patient-and family-centered Juvenile Arthritis Support Program during one year (JASP-1) for children recently diagnosed with JIA and their parents and after 12 months compare satistaction with care and health outcomes with a control group receiving standard care.
Looking for future studies?
Notify Me1 year–16 year
All sexes
Interventional
Not applicable
Stockholm, Region Stockholm, 17176, Sweden
Children diagnosed with JIA (n=50) and their parents were offered the opportunity to participate in the JASP-1 from the time of diagnosis and the following year. One year after the JIA diagnosis, the children and/or their parents were invited to answer a study-specific questionnaire comprising 16 questions. The questionnaire assessed their experiences with the information, communication, participation, and emotional support they had received during the first year with JIA. In order to compare outcomes, the questionnaire was answered by both participants in JASP-1 and patients and parents receiving standard care (n=25).
One example of a question is; If you asked questions to the health care professionals, did you get answers that you understood? Response alternatives range from "No, not at all" to "Yes, Completely" ona 5-point Likert scale.
In Swedish Pediatric Rheumatology Quality Register (PedSRQ) information about treatment, disease- and joint activity (registered by Medical doctor), and Patient Reported Outcome Measures (PROM), are measured. The total Child Health Activity Questionnaire (CHAQ-score), as well as active joints and treatment at 12 months was registered in the PedSRQ and analyzed.
The study specific questionnaire measuring patient satisfaction has been developed in collaboration with the Swedish Municipalities and County councils.
Experimental and descriptive analyses will be performed using software for statistical analysis, SPSS. Distributions of responses will be calculated in percentage. Differences in proportions between groups will be determined by performing chi-square tests.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients following the Juvenile Arthritis Support Program at the Pediatric Rheumatology Clinic
Time frame: 12 months
A study specific PREM questionnaire with 16 items. 5 point likert scale
Time frame: 12 months
One item on a 5 point likert scale, range from "not good at all" to "totally good"
Time frame: 12 months
CHAQ assesses functional ability and assists in understanding the impact of the disease on the child´s daily life. On a Visual Analog Scale (VAS) ranging 0 to 10
Time frame: 12 months
Medical doctors assessment of the childs actice joints
Region Stockholm
Other Gov
Benefits of a Juvenile Arthritis Support Program (JASP-1) for Children Recently Diagnosed With Juvenile Idiopathic Arthritis (JIA) and Their Parents
Acronym: JASP-1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03816397
Eye Diseases, JIA
Sacramento, California, United States
View Trial DetailsNCT00783510
Arthritis, Arthritis, Juvenile
Phoenix, Arizona, United States
View Trial DetailsNCT05603286
Arthritis, Arthritis, Juvenile
Utrecht, Netherlands
View Trial DetailsNCT04168034
JIA
Halifax, Nova Scotia, Canada
View Trial Details